D-0386-2021 Class III Terminated
FDA drug recall D-0386-2021 was initiated by KVK-Tech, Inc. on Apr 27, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Oct 5, 2022). Affected quantity: 17,096 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- Apr 27, 2021
- Termination Date
- Oct 5, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,096 bottles
Product description
Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot: 15684A, Exp 7/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0386-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026